The Role of In-Line Sensors in Single-Use Biomanufacturing

Single-use biomanufacturing has shifted the default expectation for process monitoring: instead of pulling manual samples and waiting for offline analysis, modern disposable bioreactors arrive with sensors already embedded in the bag, calibrated before use, and ready to stream critical data the moment a run begins. In-line sensors for parameters such as pH, dissolved oxygen, and biomass have become the practical foundation of process analytical technology (PAT) implementation in single-use facilities, enabling continuous, closed-loop control that was difficult to achieve in legacy stainless-steel environments.

In-line sensors and the case for real-time bioprocess monitoring

The case for in-line measurement rests on a straightforward principle: data collected directly inside the bioreactor in real time is more accurate and more actionable than data collected from a sample pulled minutes or hours later. The FDA's PAT guidance, published in 2004, explicitly frames in-line measurement as the most direct route to the continuous process understanding that the framework is designed to promote. This is reflected in the FDA's PAT implementation guidance. For single-use bioreactors, where opening the bag to insert a probe would destroy the sterile boundary, pre-integrated sensors are not simply convenient; they are the only practical option for in-process monitoring.

The shift from stainless-steel to single-use systems has accelerated demand for purpose-built sensor designs. Conventional electrochemical probes used in steel vessels require steam sterilization and long polarization times, making them poorly suited to disposable bags that are sterilized by gamma irradiation and used once. The PAT tool landscape for modern labs spans the full range of analytical approaches from spectroscopic probes to chemometric software, and in-line sensors form the physical measurement layer on which that broader framework depends. A review of sensor technology for disposable bioreactors published in Engineering in Life Sciences noted that the requirements for sensors in single-use systems differ fundamentally from those in reusable vessels, with cost-per-use and gamma-irradiation compatibility being among the most critical design constraints when selecting sensor interfaces.

Optical pH and dissolved oxygen sensors in single-use bioreactors

Fluorescence-based optical sensor patches are the standard in-line technology for measuring pH and dissolved oxygen in single-use bioreactors. These patches are bonded to the interior bag wall during manufacture, sterilized along with the bag by gamma irradiation, and read non-invasively by an external optoelectronic transmitter positioned against the bag exterior. Because no physical penetration of the bag is required for the transmitter, sterility is preserved throughout the run.

The sensing chemistry relies on fluorescent indicator dyes whose emission properties shift in response to changes in proton concentration or oxygen partial pressure. Optical fiber sensors can track pH fluctuations on the order of seconds, which is sufficient to capture the dynamics of stirred-tank and perfusion bioreactor processes, according to a 2025 review of optical fiber bioreactor sensors. Carbon dioxide sensor patches operate on similar fluorescence principles and are increasingly integrated alongside pH and dissolved oxygen patches to monitor dissolved gas accumulation, which is a common concern in high-density mammalian cell cultures. Small, sustained deviations in pH or dissolved oxygen can shift growth rates, promote undesirable by-product formation, and in extreme cases lead to culture collapse, making continuous in-line monitoring critical.

Gamma irradiation does introduce a technical challenge: acidic gases and ozone generated during irradiation can bleach the active dye in pH sensor patches, degrading calibration performance. This has led to specialized sensor port designs that shield patches from residual air pockets in the bag assembly during sterilization, ensuring that the factory-set two-point calibration remains valid at the start of each production run.

In-line biomass sensing: Capacitance sensors for viable cell monitoring

Viable cell concentration is one of the most important parameters in mammalian cell culture, yet it has historically been measured offline, requiring a bioreactor sample to be removed and analyzed by a separate cell counter. Capacitance-based in-line sensors address this gap by measuring the dielectric properties of intact, metabolically active cells in real time from inside the bioreactor.

The physical principle involves applying an alternating electric field across the cell suspension. Cells with intact membranes act as capacitors, polarizing in response to the field and generating a measurable signal proportional to the viable cell volume. Dead or lysed cells, whose membranes are no longer intact, do not contribute to the signal, giving capacitance measurements a selectivity for viability that optical density measurements cannot match. A study of capacitance sensor scale-up in Chinese hamster ovary cell culture demonstrated comparable linear regression models for predicting viable cell concentration across single-use bioreactor scales ranging from 50 to 2,000 L, establishing that the approach is scalable and GMP-compatible for production use when monitoring biomass online.

Multi-frequency scanning has improved the accuracy of capacitance measurements over single-frequency systems, particularly during the death phase of cultures when cell size and morphology shift. By acquiring a full dielectric spectrum rather than a single frequency point, multi-frequency sensors capture biophysical changes that single-frequency measurements can miss, making them better suited to the variable conditions of late-stage fed-batch and extended perfusion runs.

Together, these developments reflect a broader landscape of in-line sensor technologies used in single-use bioreactors (Table 1).

Table 1: Comparison of primary in-line sensor technologies for single-use bioreactors, showing measurement principle, target parameter, and key implementation considerations.

Connecting in-line sensor data to closed-loop process control

The value of in-line sensors is fully realized only when their outputs feed directly into automated control systems. Within a PAT framework, continuous sensor streams enable closed-loop control strategies in which deviations from target set points trigger automatic corrective actions such as adjustments to gas sparging, base addition, or feed delivery, without requiring manual operator intervention. This is the model described in the FDA's Guidance for Industry on PAT: a manufacturing system designed to ensure quality in real time rather than testing it into the product after the fact.

Process control systems receive sensor data via standard communication protocols and integrate it with manufacturing execution systems to generate batch records, flag deviations, and support real-time release strategies. Connecting this sensor infrastructure to the broader next-generation process analytics ecosystem that bridges laboratory measurement with industrial quality control is a critical design consideration for facilities pursuing continuous real-time release. Data management infrastructure must be in place to handle the volume and velocity of continuous sensor streams, and analytical models, including chemometric calibrations for spectroscopic sensors, must be maintained and revalidated when process conditions or sensor lots change.

Improving Oral Bioavailability Prediction With Human Models

Join this webinar to explore how an integrated human gut/liver microphysiological system (MPS), combined with mechanistic modeling, provides deeper insight into oral drug disposition.
View Webinar

Advertisement

Modern sensor tools reviewed in the context of cell culture monitoring confirm that Industry 4.0 integration is now a key design criterion: sensors must not only measure accurately but also communicate reliably with programmable logic controllers, distributed control systems, and supervisory control and data acquisition platforms in a format that supports automated process control and GMP-compliant audit trails, as described in a 2022 review of modern cell culture sensing tools.

Leachables, extractables, and qualification of single-use sensors

Any component that contacts the drug substance in a single-use bioprocess system is subject to leachables and extractables evaluation, and in-line sensors are no exception. Sensor materials, including the polymer matrix of fluorescent patches, adhesives used to bond them to bag film, and any cables or connectors passing through bag walls, must be characterized for chemical compounds that could migrate into the culture and ultimately into the drug product.

The regulatory framework for this evaluation has tightened considerably. USP chapter 665 became mandatory in May 2026, establishing enforceable standards for extractables testing of plastic components in pharmaceutical manufacturing. Prior to mandatory status, industry and regulators had been working toward standardization of extractables and leachables approaches for single-use systems. This was outlined in a review published in the Journal of Chemical Technology and Biotechnology that examined risk assessment approaches for single-use technology adoption. Gaps in leachables and extractables documentation remain among the most common technical deficiencies cited in regulatory submissions for biologic drug products manufactured using single-use systems.

Sensor qualification, therefore, extends beyond performance verification to include biocompatibility testing, particle generation assessments, and compatibility with the sterilization process. These requirements can extend development timelines for new sensor designs and impose additional documentation obligations on manufacturers using novel sensor materials.

In-line sensors as standard infrastructure for single-use bioprocessing

In-line sensors in single-use biomanufacturing have moved from promising innovation to standard infrastructure across development-scale and GMP production environments. Real-time pH, dissolved oxygen, and biomass data generated continuously inside the bioreactor bag now support the closed-loop control and data-driven process understanding that the FDA's PAT framework has long described as the target state for modern pharmaceutical manufacturing. Addressing remaining challenges, including lot-to-lot sensor variability, long equilibration times for some optical pH sensors, and the growing complexity of data management infrastructure, will determine how far real-time release strategies can advance in single-use facilities.

The next frontier in single-use sensor integration involves extending measurement coverage to additional parameters such as dissolved carbon dioxide, glucose, lactate, and off-gas composition, bringing metabolic monitoring inside the bag in the same way that physical parameter sensing already is integrated. As sensor density increases and multivariate analytical models mature, the combination of high-frequency in-line data and automated control logic offers a path to biomanufacturing processes that are genuinely responsive to the cell culture environment rather than operating on fixed schedules derived from historical batch averages.

This content includes text that has been created with the assistance of generative AI and has undergone editorial review before publishing. Technology Networks' AI policy can be found here.